Modified-Release Drug Formulations

Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores

Donald Loveday, Ph.D.; Bill McCarthy; Doug Hovey

SPI Pharma

Taste Masking Formulations

Formulating Flexibility with ActiMask® Taste Masking

SPI Pharma

Formulation

Incorporating Patient Voices from the Start of Drug Development

Bill McCarthy

SPI Pharma

ODT

Introducing UltraBurst, the Fastest Rapidly Disintegrating Product

John McInerney

SPI Pharma

Orally Disintegrating Tablets

A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs

Bill McCarthy; Geetha Thanga Mariappan, Ph.D.

SPI Pharma

The Future of Healthcare

How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?

SPI Pharma

The Future of Healthcare

How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?

SPI Pharma

The Future of Healthcare

How is SPI Pharma Innovating through the Pandemic and Beyond to Define the Future of Healthcare?

SPI Pharma

Excipients

New Mannitol Formulations Are a Gem of a Collection

Graeme MacLeod; Bill McCarthy

SPI Pharma

Future of Healthcare

How is SPI Pharma Preparing to Face the Future of Healthcare?

SPI Pharma

Virtual Panel

Reprioritizing to Bring FY2020 into Focus

Sarath Chandar; Graeme MacLeod; Jeanne Thoma (former); Joe Rogus; John Creighton; Coralyn Gonzalez; Jon Struthers

SPI Pharma

Orally Disintegrating Tablets

Creating Value with Tailored ODT Solutions

Graeme MacLeod

SPI Pharma

Formulation

Investing in New Technologies for Innovative Functional Solutions

Sarath Chandar

SPI Pharma

Focusing on Patient Compliance

Nice Insight